Overview A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion Status: Completed Trial end date: 2015-06-01 Target enrollment: Participant gender: Summary Evaluate the safety and efficacy of ophthalmic intravitreal injection of ALG-1001 in human subjects with symptomatic focal vitreomacular adhesion Phase: Phase 2 Details Lead Sponsor: Allegro Ophthalmics, LLCTreatments: Pharmaceutical Solutions